About
Moon Surgical's Maestro Platform is a next-generation robotic surgical assistance system built for the modern operating room. Designed with a light-touch philosophy, Maestro integrates a robotic arm assistant for laparoscopic surgery with an intelligent software layer called Maestro Insights, delivering real-time and post-operative performance analytics to surgical teams. The system received FDA clearance and has been validated in first-in-human studies for laparoscopic cholecystectomies, making it one of the most accessible robotic platforms for high-volume surgical environments. In 2025, Moon Surgical launched ScoPilot™, the industry's first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan, enabling autonomous camera navigation during procedures. Unlike large, costly robotic systems that require full OR overhauls, Maestro is engineered to integrate seamlessly with existing laparoscopic setups and preferred instruments, lowering the barrier to robotic adoption. Maestro Insights provides surgeons and hospital administrators with data-driven feedback to improve surgical performance, reduce variability, and optimize OR workflows. Targeted at hospitals, surgical centers, and healthcare professionals, the platform represents a scalable, sustainable path toward the fully digitalized OR of the future.
Key Features
- Robotic Laparoscopic Assistance: A lightweight robotic arm assistant that gives surgeons total control over instrument positioning during laparoscopic procedures, reducing fatigue and improving precision.
- ScoPilot™ AI Intraoperative Capability: The industry's first AI-enhanced intraoperative feature, powered by NVIDIA Holoscan, enabling autonomous camera navigation and real-time surgical guidance.
- Maestro Insights Software: An intelligent analytics layer that captures surgical performance data and delivers actionable insights to surgeons and OR administrators for continuous improvement.
- Seamless OR Integration: Designed to work with existing laparoscopic instruments and workflows, lowering the cost and complexity of adopting robotics in any operating room.
- Digitalized Operating Room: End-to-end digitalization of the OR environment, supporting sustainability goals and enabling data-driven decision-making across surgical teams.
Use Cases
- Robotic-assisted laparoscopic cholecystectomy in high-volume hospital settings
- AI-guided camera navigation during minimally invasive abdominal surgery using ScoPilot™
- Post-operative performance analytics for surgical quality improvement programs
- Digitalization of operating room workflows to improve efficiency and sustainability
- Expanding robotic surgery access to community hospitals and ambulatory surgical centers without full OR replacement
Pros
- Accessible Robotic Technology: Unlike large robotic systems requiring full OR replacement, Maestro integrates with existing setups, making robotic-assisted surgery viable for more hospitals.
- FDA Cleared with Clinical Validation: The platform has received FDA clearance and has been validated in first-in-human laparoscopic studies, ensuring safety and regulatory compliance.
- AI-Powered Intraoperative Guidance: ScoPilot™ brings real-time AI assistance into the surgical field, powered by NVIDIA Holoscan, improving camera control and reducing cognitive load on the surgeon.
- Data-Driven Performance Insights: Maestro Insights helps surgical teams track, analyze, and improve performance over time with structured post-operative analytics.
Cons
- Enterprise Pricing Only: As a medical device platform, Maestro is priced for hospital and surgical center procurement, with no publicly available pricing or trial options.
- Limited to Laparoscopic Procedures: The current platform is focused on laparoscopic surgery, which may limit applicability for surgical teams working across a broader range of specialties.
- Requires Staff Training and Onboarding: Integrating a new robotic platform into OR workflows requires training time and change management, which can slow initial adoption.
Frequently Asked Questions
What is the Maestro System by Moon Surgical?
The Maestro System is an FDA-cleared robotic surgical assistance platform designed to support laparoscopic procedures. It combines a robotic arm assistant with AI-powered software to enhance surgeon performance, reduce OR variability, and digitalize hospital operating rooms.
What is ScoPilot™ and how does it work?
ScoPilot™ is the industry's first AI-enhanced intraoperative capability on the Maestro platform. Powered by NVIDIA Holoscan, it provides autonomous camera navigation during laparoscopic surgery, reducing the need for manual camera adjustments and allowing surgeons to focus on the procedure.
Is the Maestro System FDA cleared?
Yes, Moon Surgical received FDA clearance for the Maestro System and subsequently for ScoPilot™. It has also been validated in first-in-human studies for laparoscopic cholecystectomies.
What is Maestro Insights?
Maestro Insights is the intelligent software component of the Maestro Platform that captures and analyzes intraoperative data to deliver actionable performance insights for surgeons and OR administrators.
Who is the Maestro Platform designed for?
The Maestro Platform is designed for hospitals, surgical centers, and healthcare professionals performing laparoscopic procedures who want to improve surgical performance, reduce costs, and move toward a fully digitalized operating room.
